Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Osteosarcoma × penpulimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 4 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Rectal Neoplasms 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Paraganglioma, Extra-Adrenal 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Osteosarcoma 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma 1 Gynecological Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Diseases 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Ifosfamide 27 Methotrexate 23 Doxorubicin 21 Cyclophosphamide 20 Cisplatin 19 Filgrastim 15 Etoposide 15 Gemcitabine 14 Leucovorin 12 Magnetic Resonance Spectroscopy 10 Temozolomide 9 Specimen Handling 9 Granulocyte Colony-Stimulating Factor 8 fludarabine 7 Zoledronic Acid 7 X-Rays 7 Sirolimus 7 Nivolumab 7 Neoadjuvant Therapy 7 Irinotecan 7 Docetaxel 7 Carboplatin 7 Biopsy 7 apatinib 6 Phantoms, Imaging 6 Mesna 6 cabozantinib 5 Vincristine 5 Topotecan 5 Radiotherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06114225 2023-11-02

PROMIS

Ruijin Hospital

Phase 2 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡